While prof Mandal from IIT-Guwahati ranks 234 out of 50,331 scientists worldwide in the primary field “Biomedical Engineering”, his wife is ranked at 394. The list is prepared after assessing scientists from across the world for their career-long research citation impact from data collected until 2019.
Twenty-two researchers from IIT-Guwahati made it to the list, but the couple’s story ought to stand out.
“We are in our late 30s and we feel the journey has just begun. Impact of our research contributions getting recognized so early in our academic career is an honour and we thank everyone who directly or indirectly contributed to our progress,” Dr Mandal told TOI on Wednesday.
Nandana specialises in soft tissue engineering and cartilage repair using biomaterial and stem cells. She has published 27 international articles with cumulative impact factor of 200+ having 5700+ citations with an H-index of 19. On the other hand, Mandal has 141 research articles with a total cumulative impact factor of 748+, 10 cover pages, nine books and chapters, and 17 patents (4 US and 13 Indian citizens) with a high number of citations (5,300+) with an H-index of 38. Based on this research impact in the field, their works were acknowledged.
While Dr Mandal is a professor at biosciences and bioengineering department and associate dean, academics (UG) IIT-Guwahati, Dr Nandana is working as a senior research scientist with a Stanvac-Superon Group and associated as a guest faculty at IIIT-Guwahati.
As independent researchers, their expertise is on using “Indian endemic silk”, including Assam’s most popular “Muga and Eri Silk”, to create cutting edge technologies in an effort to cater the societal healthcare needs.
“One of the potent problems we are addressing is how to create affordable human functional organs and tissues using 3D bioprinting, which could be transplanted to save human lives. Every year, millions of patients suffer loss or failure of an organ or tissue as a result of accidents or disease. Organ transplantation is a commonly accepted medical norm under these circumstances,” Mandal said.
He, however, said constant shortage of donor tissue and organ transplants due to non-availability of donors has spurred great interest for lab-grown bio-engineered tissues and organs as promising substitute to save patients’ lives.